www.fgks.org   »   [go: up one dir, main page]

Revised: 27 May 2024

Information for Industry

Categorisation of Products

Ingredients
Purpose for use
Other sources of information
Categorisation guidance
Excluded products
Requesting a Product Categorisation
Definitions

We have prepared this information to help those wishing to market products understand the factors that determine the category under which a product is regulated. It provides guidance in determining whether a product is a therapeutic product, and if so, whether it is medicine, a medical device or a related product.

The categorisation of a product is determined by its ingredients, its purpose for use and the manner in which it is presented in the market.

Ingredients

Products marketed as dietary supplements, supplemented foods, cosmetics, or related products are not permitted to contain ingredients scheduled as:

Check Medsafe's Classification database to determine if an ingredient is scheduled under the Medicines Act. When searching for a substance in the schedule, remember to check synonyms if the initial search gives a "not found" result.

The Schedules at the end of the Misuse of Drugs Act contain the lists of controlled drugs.

The Cosmetic Product Group Standard includes lists of substances, with conditions, that can be included in cosmetics. These do not include substances that are scheduled as controlled drugs under the Misuse of Drugs Act 1975 or scheduled as prescription medicines, restricted (pharmacist-only) medicines or pharmacy-only medicines under the Medicines Act 1981. The Environmental Protection Authority (EPA) administers the Cosmetic Product Group Standard.

Purpose for use

A fundamental consideration is whether you intend your product to have a therapeutic purpose. The Medicines Act has a broad definition for therapeutic purpose.

If you intend to have a therapeutic purpose for your product, it will be categorised as a medical device, a medicine or related product.

The purpose for use may be stated or implied in any of the following:

  • the product label statements and claims
  • websites
  • depictions and context of advertising. For example, advertising depicting a pharmacist selling a product to a patient could suggest it has a therapeutic purpose
  • education sessions
  • testimonials
  • provision of, references to or links to information about past or present traditional use
  • social media posts and use of influencer-generated material
  • television, radio, digital and print media
  • the product meets the definition of a medicine in the Medicines Act
  • the expected use of the product.

Therapeutic claims are not permitted for products supplied as dietary supplements, supplemented foods or cosmetics.

You can seek independent advice on whether a claim implies a therapeutic purpose.

Other sources of information

Distributors wishing to import unprocessed plant or animal material should contact NZ Biosecurity to determine which import standards apply.

The New Zealand Customs Service can advise on the requirements for commercial importation.

Categorisation guidance

Figure 1 is a guide to help determine the appropriate regulatory coverage for a product.  Please note that the legal definition for a medical device in New Zealand may be different to that in other countries.  Therefore, even when a product has been accepted as a medical device in other international jurisdictions, it is important to check that it meets the definition of medical device in the Medicines Act 1981 before it is supplied and notified to WAND. Refer to the Definitions section below.

Table 1 provides categorisation information for various types of products as determined when the definitions were amended 1 July 2014. The examples shown in the table are product types that lie close to the medicine / medical device interface.

Figure 1: Flowchart to determine the appropriate regulatory coverage for a product

See the Definitions section for an explanation of the terms in the flowchart

 

Figure 1

 

View larger version (pdf, 1 page 122 KB)

Table 1: Categorisation information by product type (listed in alphabetical order)

Product type Category
Absorbable intra-ocular and synovial visco-elastic fluids used in surgery Medical device
Artificial tears or saliva Medical device
Blood bags with / without anticoagulant / preservative Medical device
Bone cement with antibiotic Medical device
Catheter with heparin / antibiotic coating Medical device
Combination pack which includes one or more approved medicines in an approved package, with or without a medical device, related product or cosmetic (eg, approved head lice treatment in its approved package combined with a combing conditioner and a comb). Medicine
Contact lens lubricants and solutions Medical device
Condoms with spermicide / viricide / local anaesthetic Medical device
Cryogenic liquids for use with an applicator for cryogenic therapy, where the mode of action is freezing resulting from evaporation Medical device
Dental cement with antibiotic / adrenaline Medical device
Dermal fillers (eg, collagen injections) with / without local anaesthetic included in the formulation Medical device
Douches for body "cleaning" Medical device
Haemodialysis solutions Medical device
Haemostatic agents – where the only action is absorption of fluid Medical device
Haemostatic agents – fibrin Medicine
Hormone eluting intra-uterine contraceptive devices Medicine
Injectable contrast agents for use in diagnostic imaging (eg, CAT, NMR, X-Ray, ultrasound) Medicine
Intra-uterine contraceptive devices other than hormone eluting IUCDs (includes copper containing IUCDs) Medical device
In-vitro pregnancy tests Medical device
Irradiating apparatus Medical device
Lubricating gels without local anaesthetic included in the formulation Medical device
Manuka honey dressings provided the action of the honey is not described as being an antibiotic / antibacterial Medical device
Medicated dressings where the primary purpose of the dressing is to cover and protect the wound and provide an environment that supports healing (in contrast to being a delivery mechanism for a medicine). Medical device
Peritoneal dialysis solutions and substances Medicine
Procedure kits (no medicines included) Medical device
Procedure kits which include an approved medicine in its original pack Medical device
Saline nasal sprays Medical device
Saline for injection Medicine
Solutions for irrigation Medical device
Tamponade solutions for eye surgery Medical device
Tissue adhesives (including fibrin based) Medical device
Toothpastes for sensitive teeth where the mode of action is physical (eg, by blocking open pores).
  • Fluoride content (if any) must be no greater than that allowed in a general sales medicine.
  • Note that inclusion of potassium nitrate in a toothpaste makes it a medicine.
Medical device
Total Parenteral Nutrition (TPN) solutions Medicine
Transdermal patches Medicine
Vascular balloons with / without medicinal coating Medical device
Urea ointment for nail debridement Medical device
Ultrasonic therapy apparatus Medical device
Water for injection Medicine

Products that are excluded from regulation under the Medicines legislation

Section 58A of the Medicines Regulations 1984 excludes some products from regulation as therapeutic products if certain conditions are met, including limits on the therapeutic claims that can be made.

The excluded products include some dentifrices, some anti-dandruff hair products, some anti-acne skin care products, some barrier creams, and some anti-bacterial skin products. See Table 2 for more information.

Table 2: Types of products and the conditions to be met in order for those products to be excluded from regulation under the Medicines Act 1981

Conditions Notes
Oral hygiene products (eg, toothpaste, mouthwash)

The product must not contain a substance which, in the amount or concentration present, is a scheduled medicine.

The claimed benefits from use of the product relate only to:

  • improvements in oral hygiene and/or
  • prevention of tooth decay (including reference to the use of fluoride for the prevention of tooth decay).

The claimed benefits do not refer to the prevention or treatment of tooth sensitivity.

The labelling or promotional material must not refer to other benefits from use of the product, such as prevention or treatment of tooth sensitivity, gum disease or other oral disease or periodontal conditions.

The products must comply with the requirements specified in the Cosmetic Product Group Standard administered by EPA.

Anti-dandruff hair care products (eg, shampoos, conditioners)

The product must not contain a substance which, in the amount or concentration present, is a scheduled medicine.

The claimed benefits from use of the product relate only to the prevention or control of dandruff through cleansing, moisturising, exfoliating or drying the scalp.

The labelling or promotional material must not refer to other benefits from use of the product, such as prevention or treatment of fungal infections of the scalp.

The products must comply with the requirements specified in the Cosmetic Product Group Standard administered by EPA.

Anti-acne skin care products (eg, cleansers, face scrubs and masks, spot treatments)

The product must not contain a substance which, in the amount or concentration present, is a scheduled medicine.

The claimed benefits from use of the product relate only to the prevention or control of acne through cleansing, moisturising, exfoliating or drying the skin.

 

Barrier creams (eg, hand creams, nappy rash creams)

The product must not contain a substance which, in the amount or concentration present, is a scheduled medicine.

The claimed benefits from use of the product relate only to the prevention or control of skin irritation, dryness or damage, by the creation of a protective barrier to moisture.

The labelling or promotional material must not refer to other benefits from use of the product, such as prevention or treatment of fungal or bacterial skin infections.

The products must comply with any requirements specified in the Cosmetic Product Group Standard administered by EPA.

Antibacterial skin products

All of the following conditions must be met for the exclusion to apply:

  •  the product does not contain a substance which, in the amount or concentration present, is specified in Schedule 1 of the Medicines Regulations 1984
  •  a therapeutic purpose is not claimed for the product other than that it can be used for preventing the spread of bacteria
  • the product is not claimed to be effective against a named bacterium
  •  the product is not presented as being for use in any procedure associated with the transmission of disease from contact with blood or other bodily fluids
  •  the product is not presented as being for use in any procedure relating to the piercing of skin or mucous membrane for any purpose
  •  the product is not presented as being for use in any procedure relating to venipuncture or the delivery of an injection, and
  •  the product is not recommended for use in connection with the provision of a health service (as defined in section 2 of the Health and Disability Commissioner Act 1994).

The product is a medicine if any one or more of the statements listed above applies to the product.

The product is not recommended for use in connection with the provision of health services (as defined in section 2 of the Health and Disability Commissioner Act 1994).

The excluded products must comply with the requirements specified in the Cosmetic Product Group Standard administered by EPA.

Requesting a Product Categorisation from Medsafe

If you need assistance to determine whether a product is a medicine or a medical device, you can submit a request to Medsafe for the categorisation status of the product.

Please provide the following information with the request.

  • Name and contact details of the importer/supplier in NZ
  • Name and location details of the manufacturer
  • Name of the product
  • A description of the purpose of the product
  • Information about the mode(s) of action of the product
  • A description of the form of the product
  • Information about any regulatory approvals the product has from other regulators or notified bodies including:
    • the name of the regulator/notified body
    • the type of approval granted (CE Mark, FDA 510k, FDA Pre Market Assessment, TGA Registration or Inclusion, etc)
    • A copy of the promotional material for the product
    • URL of a website detailing the product
    • A copy of the product label

Medsafe may also request further information about the product to make the categorisation decision.

Please submit the above information to Medsafe by email: askmedsafe@health.govt.nz

Definitions

Therapeutic purpose

Therapeutic purpose - means any of the following purposes, or a purpose in connection with any of the following purposes:

  1. preventing, diagnosing, monitoring, alleviating, treating, curing, or compensating for, a disease, ailment, defect, or injury; or
  2. influencing, inhibiting, or modifying a physiological process; or
  3. testing the susceptibility of persons to a disease or ailment; or
  4. influencing, controlling, or preventing conception; or
  5. testing for pregnancy; or
  6. investigating, replacing, or modifying parts of the human anatomy

Medicine

  1. means any substance or article that -
    1. is manufactured, imported, sold, or supplied wholly or principally for administering to 1 or more human beings for a therapeutic purpose; and
    2. achieves, or is likely to achieve, its principal intended action in or on the human body by pharmacological, immunological, or metabolic means; and
  2. includes any substance or article -
    1. that is manufactured, imported, sold, or supplied wholly or principally for use as a therapeutically active ingredient in the preparation of any substance or article that falls within paragraph (a); or
    2. of a kind or belonging to a class that is declared by regulations to be a medicine for the purposes of the Medicines Act; but
  3. does not include -
    1. a medical device; or
    2. any food within the meaning of section 2 of the Food Act 1981; or
    3. any radioactive material within the meaning of section 5(1) of the Radiation Safety Act 2016; or
    4. any animal food in which a medicine (within the meaning of paragraph (a) or (b)) is incorporated; or
    5. any animal remedy; or
    6. any substance or article of a kind or belonging to a class that is declared by regulations not to be a medicine for the purposes of the Medicines Act.

Medical device

  1. means any device, instrument, apparatus, appliance, or other article that -
    1. is intended to be used in, on, or for human beings for a therapeutic purpose; and
    2. does not achieve its principal intended action in or on the human body by pharmacological, immunological, or metabolic means (but may be assisted in its function by such means); and
  2. includes a material that -
    1. is intended to be used in or on human beings for a therapeutic purpose; and
    2. does not achieve its principal intended action in or on the human body by pharmacological, immunological, or metabolic means (but may be assisted in its function by such means); and
  3. also includes -
    1. anything that is intended to be used with a device, instrument, apparatus, appliance, article, or material referred to in paragraph (a) or (b) to enable the device, instrument, apparatus, appliance, article, or material to be used as its manufacturer intends; and
    2. any device, instrument, apparatus, appliance, article, or material of a kind or belonging to a class that is declared by regulations to be a medical device for the purposes of the Medicines Act; but
  4. does not include a device, instrument, apparatus, appliance, article, or material of a kind or belonging to a class that is declared by regulations not to be a medical device for the purposes of the Medicines Act.

Related product

A related product is defined in section 94 of the Medicines Act 1981. A related product is a cosmetic or dentifrice or food in respect of which a claim is made that the substance or article is effective for a therapeutic purpose. It does not include any medicine.

A product that is used "wholly or principally" for a therapeutic purpose is a medicine. A related product has a therapeutic purpose that is not its principal purpose (eg, a fluoride toothpaste, where the principal purpose is to clean the teeth).

Many products at the food-therapeutic product interface are likely to be related products (eg, a capsule containing vitamins and minerals where the principal purpose is to supplement the dietary intake of those substances).

Supplemented food

A product is considered a supplemented food if it is represented as a food that has a substance or substances added to it or that has been modified in some way to perform a physiological role beyond the provision of nutritive requirement.

Supplemented foods are regulated under the Food Act 2014 and are subject to the NZ Food (Supplemented Food) Standards 2010.

Dietary supplement

Dietary supplements are regulated under the Food Act 2014 and are subject to the Dietary Supplements Regulations 1985 (administered by Medsafe). These regulations specify a number of requirements for dietary supplements relating to matters such as composition, labelling and maximum permitted daily doses for many vitamins and minerals.

Cosmetic

A product is a cosmetic if it is used to beautify, cleanse or protect the hair, skin, teeth or complexion.

Refer to the Cosmetic Product Group Standard, published by the Environmental Protection Authority (EPA) under the Hazardous Substances and New Organisms (HSNO) legislation. This group standard includes lists of chemicals whose use in cosmetics is restricted.

Refer also to regulations 22, 24 and 26-36 of the Medicines Regulations 1984 for requirements that apply to cosmetics.

"Therapeutic type" dose form

A therapeutic type dose form is a presentation of the product in a form generally used in pharmaceuticals such as tablets, capsules and controlled amounts of oral liquids or powders.

Psychoactive substances

Psychoactive substances are regulated under the Psychoactive Substances Act 2013. This act contains the definition of psychoactive substances.

See the Psychoactive substances regulation page on the Ministry of Health website for more information.

Show menus
0 1 2 4 5 6 7 9 [ /